• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调强放射治疗(IMRT)交付和质量保证(QA)中 MLC 校准误差的生物学后果。

Biological consequences of MLC calibration errors in IMRT delivery and QA.

机构信息

British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver, British Columbia, Canada.

出版信息

Med Phys. 2012 Apr;39(4):1917-24. doi: 10.1118/1.3692177.

DOI:10.1118/1.3692177
PMID:22482613
Abstract

PURPOSE

The purpose of this work is threefold: (1) to explore biological consequences of the multileaf collimator (MLC) calibration errors in intensity modulated radiotherapy (IMRT) of prostate and head and neck cancers, (2) to determine levels of planning target volume (PTV) and normal tissue under- or overdose flagged with clinically used QA action limits, and (3) to provide biologically based input for MLC QA and IMRT QA action limits.

METHODS

Ten consecutive prostate IMRT cases and ten consecutive head and neck IMRT cases were used. Systematic MLC offsets (i.e., calibration error) were introduced for each control point of the plan separately for X1 and X2 leaf banks. Offsets were from - 2 to 2 mm with a 0.5 mm increment. The modified files were imported into the planning system for forward dose recalculation. The original plan served as the reference. The generalized equivalent uniform dose (gEUD) was used as the biological index for the targets, rectum, parotid glands, brainstem, and spinal cord. Each plan was recalculated on a CT scan of a 27 cm diameter cylindrical phantom with a contoured 0.6 cc ion chamber. Dose to ion chamber and 3D gamma analysis were compared to the reference plan. QA pass criteria: (1) at least 95% of voxels with a dose cutoff of 50% of maximum dose have to pass at 3 mm/3% and (2) dose to chamber within 2% of the reference dose.

RESULTS

For prostate cases, differences in PTV and rectum gEUD greater than 2% were identified. However, a larger proportion of plans leading to greater than 2% difference in prostate PTV gEUD passed the ion chamber QA but not 3D gamma QA. A similar trend was found for the rectum gEUD. For head and neck IMRT, the QA pass criteria flagged plans leading to greater than 4% differences in PTV gEUD and greater than 5% differences in the maximum dose to brainstem. If pass criteria were relaxed to 90% for gamma and 3% for ion chamber QA, plans leading to a 5% difference in PTV gEUD and a 5%-8% difference in brainstem maximum dose would likely pass IMRT QA. A larger proportion of head and neck plans with greater than 2% PTV gEUD difference passed 3D gamma QA compared to ion chamber QA.

CONCLUSIONS

For low modulation plans, there is a better chance to catch MLC calibration errors with 3D gamma QA rather than ion chamber QA. Conversely, for high modulation plans, there is a better chance to catch MLC calibration errors with ion chamber QA rather than with 3D gamma QA. Ion chamber and 3D gamma analysis IMRT QA can detect greater than 2% change in gEUD for PTVs and critical structures for low modulation treatment plans. For high modulation treatment plans, ion chamber and 3D gamma analysis can detect greater than 2% change in gEUD for PTVs and a 5% change in critical structure gEUD since either QA methods passes the QA criteria. For gEUD changes less than those listed above, either QA method has the same proportion of passing rate.

摘要

目的

本研究旨在:(1)探讨多叶准直器(MLC)校准误差对前列腺癌和头颈部癌症调强放疗(IMRT)的生物学后果,(2)确定计划靶区(PTV)和正常组织在临床使用的 QA 动作限制下的剂量低于或高于规定剂量的水平,(3)为 MLC QA 和 IMRT QA 动作限制提供基于生物学的输入。

方法

使用了 10 例连续前列腺 IMRT 病例和 10 例连续头颈部 IMRT 病例。分别针对计划的每个控制点的 X1 和 X2 叶片组引入系统的 MLC 偏移(即校准误差)。偏移量从-2 到 2 毫米,增量为 0.5 毫米。修改后的文件被导入规划系统进行正向剂量重新计算。原始计划作为参考。广义等效均匀剂量(gEUD)被用作目标、直肠、腮腺、脑干和脊髓的生物学指标。每个计划都在一个直径为 27 厘米的圆柱形模体的 CT 扫描上进行计算,该模体上有一个轮廓为 0.6 cc 的离子室。对离子室和 3D 伽马分析与参考计划进行了比较。QA 通过标准:(1)剂量截止值为最大剂量的 50%的至少 95%的体素必须通过 3 毫米/3%,(2)腔室内的剂量在参考剂量的 2%以内。

结果

对于前列腺病例,发现 PTV 和直肠 gEUD 的差异大于 2%。然而,导致前列腺 PTV gEUD 差异大于 2%的较大比例计划通过了离子室 QA,但未通过 3D 伽马 QA。直肠 gEUD 也出现了类似的趋势。对于头颈部 IMRT,QA 通过标准标记了导致 PTV gEUD 差异大于 4%和脑干最大剂量差异大于 5%的计划。如果将伽马的通过标准放宽到 90%,将离子室 QA 的通过标准放宽到 3%,那么导致 PTV gEUD 差异大于 5%和脑干最大剂量差异大于 5%-8%的计划可能会通过 IMRT QA。与离子室 QA 相比,更多的头颈部计划 PTV gEUD 差异大于 2%通过了 3D 伽马 QA。

结论

对于低调制计划,3D 伽马 QA 比离子室 QA 更有可能捕捉到 MLC 校准误差。相反,对于高调制计划,离子室 QA 比 3D 伽马 QA 更有可能捕捉到 MLC 校准误差。离子室和 3D 伽马分析 IMRT QA 可以检测到 PTV 和关键结构的 gEUD 变化大于低调制治疗计划的 2%。对于高调制治疗计划,离子室和 3D 伽马分析可以检测到 PTV 和关键结构 gEUD 的变化大于 2%,并且由于任何 QA 方法都通过了 QA 标准,因此关键结构 gEUD 的变化大于 5%。对于小于上述 gEUD 变化的情况,任何 QA 方法的通过率都相同。

相似文献

1
Biological consequences of MLC calibration errors in IMRT delivery and QA.调强放射治疗(IMRT)交付和质量保证(QA)中 MLC 校准误差的生物学后果。
Med Phys. 2012 Apr;39(4):1917-24. doi: 10.1118/1.3692177.
2
Clinical implementation and error sensitivity of a 3D quality assurance protocol for prostate and thoracic IMRT.前列腺和胸部调强放射治疗的3D质量保证方案的临床实施与误差敏感性
J Appl Clin Med Phys. 2015 Sep 8;16(5):179–192. doi: 10.1120/jacmp.v16i5.5392.
3
Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors.在调强放射治疗(IMRT)优化中使用生物学参数(等效均匀剂量(EUD)和正常组织并发症概率(NTCP))治疗肝内肿瘤的益处。
Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):571-8. doi: 10.1016/j.ijrobp.2005.02.033.
4
IMRT quality assurance using a second treatment planning system.使用第二个治疗计划系统进行调强放射治疗质量保证。
Med Dosim. 2010 Winter;35(4):274-9. doi: 10.1016/j.meddos.2009.09.001. Epub 2009 Oct 12.
5
Sensitivity of volumetric modulated arc therapy patient specific QA results to multileaf collimator errors and correlation to dose volume histogram based metrics.体部旋转调强弧形治疗患者特定质量保证结果对多叶准直器误差的敏感性及其与剂量体积直方图指标的相关性。
Med Phys. 2013 Nov;40(11):111715. doi: 10.1118/1.4824433.
6
On the insensitivity of single field planar dosimetry to IMRT inaccuracies.单野平面剂量学对调强放疗不敏感性。
Med Phys. 2010 Jun;37(6):2516-24. doi: 10.1118/1.3425781.
7
Analysis of direct clinical consequences of MLC positional errors in volumetric-modulated arc therapy using 3D dosimetry system.使用三维剂量测定系统分析容积调强弧形放疗中多叶准直器位置误差的直接临床后果。
J Appl Clin Med Phys. 2015 Sep 8;16(5):296–305. doi: 10.1120/jacmp.v16i5.5515.
8
Evaluation of the accuracy of 3DVH software estimates of dose to virtual ion chamber and film in composite IMRT QA.评估 3DVH 软件在复合调强放疗 QA 中对虚拟电离室和胶片剂量估计的准确性。
Med Phys. 2012 Jan;39(1):81-6. doi: 10.1118/1.3666771.
9
VMAT QA: measurement-guided 4D dose reconstruction on a patient.VMAT QA:基于测量的 4D 剂量重建患者。
Med Phys. 2012 Jul;39(7):4228-38. doi: 10.1118/1.4729709.
10
Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.预处理患者特定调强放疗质量保证:伽玛指数与患者临床剂量体积直方图的相关性研究。
Med Phys. 2012 Dec;39(12):7626-34. doi: 10.1118/1.4767763.

引用本文的文献

1
Dosimetric and mechanical equivalency of Varian TrueBeam linear accelerators.瓦里安 TrueBeam 直线加速器的剂量学和机械等效性。
J Appl Clin Med Phys. 2020 Dec;21(12):43-53. doi: 10.1002/acm2.13058. Epub 2020 Oct 18.
2
Dosimetric and radiobiological characterizations of prostate intensity-modulated radiotherapy and volumetric-modulated arc therapy: A single-institution review of ninety cases.前列腺调强放疗和容积调强弧形放疗的剂量学与放射生物学特征:单机构90例病例回顾
J Med Phys. 2016 Jul-Sep;41(3):162-8. doi: 10.4103/0971-6203.189479.
3
On the sensitivity of TG-119 and IROC credentialing to TPS commissioning errors.
关于TG-119和IROC资质认证对治疗计划系统调试误差的敏感性
J Appl Clin Med Phys. 2016 Jan 8;17(1):34-48. doi: 10.1120/jacmp.v17i1.5452.
4
Analysis of direct clinical consequences of MLC positional errors in volumetric-modulated arc therapy using 3D dosimetry system.使用三维剂量测定系统分析容积调强弧形放疗中多叶准直器位置误差的直接临床后果。
J Appl Clin Med Phys. 2015 Sep 8;16(5):296–305. doi: 10.1120/jacmp.v16i5.5515.
5
Determining the optimal dosimetric leaf gap setting for rounded leaf-end multileaf collimator systems by simple test fields.通过简单测试射野确定圆形叶端多叶准直器系统的最佳剂量学叶片间距设置。
J Appl Clin Med Phys. 2015 Jul 8;16(4):65-77. doi: 10.1120/jacmp.v16i4.5321.
6
An improvement in IMRT QA results and beam matching in linacs using statistical process control.使用统计过程控制提高直线加速器的调强放射治疗质量保证结果和射束匹配。
J Appl Clin Med Phys. 2014 Sep 8;15(5):4927. doi: 10.1120/jacmp.v15i5.4927.